144 related articles for article (PubMed ID: 30580336)
1. Understanding and Improving Diagnostic Tests: The Clinician Perspective.
Ng PC
Neonatology; 2019; 115(3):189-196. PubMed ID: 30580336
[TBL] [Abstract][Full Text] [Related]
2. A laboratorian's perspective on evaluation and implementation of new laboratory tests.
O'Kane DJ; Ebert TA; Hallaway BJ; Roberts SG; Bhuiyan AK; Tenner KS
Clin Chem; 1997 Sep; 43(9):1771-80. PubMed ID: 9299974
[TBL] [Abstract][Full Text] [Related]
3. When will less monitoring and diagnostic testing benefit the patient more?
Zampieri FG; Einav S
Intensive Care Med; 2019 Oct; 45(10):1447-1450. PubMed ID: 31375865
[No Abstract] [Full Text] [Related]
4. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests.
Shen B; Hwang J
Clin Pharmacol Ther; 2010 Dec; 88(6):754-6. PubMed ID: 21081945
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Tests to Support Late-Stage Control Programs for Schistosomiasis and Soil-Transmitted Helminthiases.
Hawkins KR; Cantera JL; Storey HL; Leader BT; de Los Santos T
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0004985. PubMed ID: 28005900
[TBL] [Abstract][Full Text] [Related]
7. Setting clinical performance specifications to develop and evaluate biomarkers for clinical use.
Lord SJ; St John A; Bossuyt PM; Sandberg S; Monaghan PJ; O'Kane M; Cobbaert CM; Röddiger R; Lennartz L; Gelfi C; Horvath AR;
Ann Clin Biochem; 2019 Sep; 56(5):527-535. PubMed ID: 30987429
[No Abstract] [Full Text] [Related]
8. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers.
Walzl G; McNerney R; du Plessis N; Bates M; McHugh TD; Chegou NN; Zumla A
Lancet Infect Dis; 2018 Jul; 18(7):e199-e210. PubMed ID: 29580818
[TBL] [Abstract][Full Text] [Related]
9. Standardized Immunomonitoring: Separating the Signals from the Noise.
Duffy D
Trends Biotechnol; 2018 Nov; 36(11):1107-1115. PubMed ID: 30343682
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
11. Proteomic-based biomarker discovery for development of next generation diagnostics.
Khalilpour A; Kilic T; Khalilpour S; Álvarez MM; Yazdi IK
Appl Microbiol Biotechnol; 2017 Jan; 101(2):475-491. PubMed ID: 28013407
[TBL] [Abstract][Full Text] [Related]
12. Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practice.
Mattes WB; Goodsaid F
Exp Biol Med (Maywood); 2018 Feb; 243(3):256-261. PubMed ID: 29110507
[TBL] [Abstract][Full Text] [Related]
13. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.
Chaabouni T; Manceau H; Peoc'h K
Ann Biol Clin (Paris); 2016 Aug; 74(4):385-94. PubMed ID: 27492691
[TBL] [Abstract][Full Text] [Related]
14. Special Section Guest Editorial: Optical Diagnostic and Biophotonic Methods from Bench to Bedside.
Kainerstorfer J; Chowdhry F; Gandjbakhche A; Tromberg B; Gannot I
J Biomed Opt; 2016 Oct; 21(10):101401. PubMed ID: 27367052
[No Abstract] [Full Text] [Related]
15. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 5. Diagnostic accuracy studies.
Manchikanti L; Derby R; Wolfer L; Singh V; Datta S; Hirsch JA
Pain Physician; 2009; 12(3):517-40. PubMed ID: 19461821
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed.
Van den Bruel A; Cleemput I; Aertgeerts B; Ramaekers D; Buntinx F
J Clin Epidemiol; 2007 Nov; 60(11):1116-22. PubMed ID: 17938052
[TBL] [Abstract][Full Text] [Related]
17. Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT Checklist.
Kip MMA; IJzerman MJ; Henriksson M; Merlin T; Weinstein MC; Phelps CE; Kusters R; Koffijberg H
Med Decis Making; 2018 Oct; 38(7):778-788. PubMed ID: 30248275
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome serum marker screening: decision criteria and implicit values.
Seror V; Costet N
Health Policy; 1998 Jan; 43(1):83-96. PubMed ID: 10178803
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery.
Whiting P; Gupta R; Burch J; Mota RE; Wright K; Marson A; Weishmann U; Haycox A; Kleijnen J; Forbes C
Health Technol Assess; 2006 Feb; 10(4):1-250, iii-iv. PubMed ID: 16487454
[TBL] [Abstract][Full Text] [Related]
20. Study design for the evaluation of diagnostic tests.
Daya S
Semin Reprod Endocrinol; 1996 May; 14(2):101-9. PubMed ID: 8796932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
